Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.
about
A practical approach to osteoporosis management in the geriatric populationA Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells.Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.The innovative medicines initiative: a public private partnership model to foster drug discovery.Osteoporosis in older persons: current pharmacotherapy and future directions.The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab.Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.The Potential of microRNAs for Stem Cell-based Therapy for Degenerative Skeletal Diseases.Seropharmacological study on osteogenic effects of post-absorption ingredients of an osteoprotective herbal formula.
P2860
Q35223327-7FD2C55E-306C-49A3-BC1B-7EB48E414B9EQ35864012-14278B97-89F6-4307-8360-EE66818F0DA8Q36600824-67D6676D-6114-45C2-8446-3424E91D9605Q37655104-77BAD7A8-E066-4961-9EAD-20CD49A40924Q38124052-8958F02F-BEA1-40AF-9480-B22C2D241207Q38193181-3DA900F1-7766-412A-8B73-3CFF3658FBECQ42024018-D7F03E55-F62D-4095-BAE9-81A3B3524FA5Q47134813-AF0DC8EB-851D-4478-BEBA-387B6072EAF9Q53081441-AE334899-A52B-41A9-AA31-22F7034BC10A
P2860
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.
@en
type
label
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.
@en
prefLabel
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.
@en
P2860
P356
P1476
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.
@en
P2093
Daniel M Riche
Emily E Sutton
P2860
P304
P356
10.1345/APH.1Q543
P407
P577
2012-07-25T00:00:00Z